On the 19th of September, NVIDIA has introduced their latest Quadro workstation graphics line up for the professionals that does a lot of in its regional launch held in Bangkok.
NVIDIA's Senior Director of Professional Solutions Group holding the new Quadro K5200.
A workstation that packs more than just a punch, powered by dual NVIDIA Quadro K5200.
Sandeep also mention on the advantages that the NVIDIA GPUs have on applications such as Adobe Illustrator which runs ten times faster on NVIDIA Quodro GPUs and it also has NVIDIA exclusive functions such as NV Path Rendering and it is available on all PC workstations.
Sandeep Also mentions that the new Quadro line ups will have extreme graphics compute power that will greatly reduce CPU usage and allow users to zoom into high resolution vector graphics and performing real-time 4K video rendering in a seamless experience. The performance is easily perceived when you are running applications such as Illustrator, Premiere Pro, Maya and etc.
Imagine the future where things can be done much faster with GPU cloud computing that enable collaborative and interactive 3D experience on notebook PCs, tablets or even smartphones. Under ideal Quadro setting, the Iray client is paired with a powerful network-attached appliance that harnesses the power of the highest-performing NVIDIA GPUs known as Visual Computing Appliance (VCA) to deliver high quality images faster from within the network or remotely.
“Iray is the world's first GPU accelerated and physically correct, photo-realistic rendering solution. With Quadro and VCA, it is able to achieve rendering speeds that dramatically reduces the iterative creative process of perfecting a design. Unlike most production renderers, Iray delivers results that reflect real-world behaviors,” added Sandeep.
This technology could do a great help in scientific research, especially the renown project of protein folding simulation study known as Folding@home initiated by Stanford University for the purpose of studying Alzheimer's, Huntington's, Parkinson's, and many cancerous disease.